Kim Chan Kyo, Park Byung Kwan, Lee Hyun Moo, Kim Sam Soo, Kim EunJu
Department of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Ilwon-dong, Kangnam-gu, Seoul, Republic of Korea 135-710.
AJR Am J Roentgenol. 2008 May;190(5):1180-6. doi: 10.2214/AJR.07.2924.
The purpose of this study was to evaluate the diagnostic performance of dynamic contrast-enhanced MRI (DCE-MRI) and of T2-weighted MRI with diffusion-weighted imaging (DWI) for predicting local tumor progression after high-intensity focused ultrasonic ablation of localized prostate cancer.
Twenty-seven patients who had increased levels of prostate-specific antigen after high-intensity focused ultrasonic ablation underwent MRI and endorectal biopsy. The MR images and biopsy results were correlated for six prostate sectors. Residual or recurrent prostate cancer after treatment was defined as local tumor progression if the biopsy results showed cancer foci. Two readers blinded to the clinical findings and biopsy results used a 5-point scale to independently assess DCE-MR images and T2-weighted and diffusion-weighted MR images. The results were compared by use of the McNemar test with Bonferroni correction, generalized estimating equations, and receiver operating characteristic analysis.
After high-intensity focused ultrasonic ablation, local tumor progression was pathologically detected in 54 (33%) of 162 sectors in 18 patients. The sensitivities of DCE-MRI and T2-weighted MRI with DWI were 80% and 63% for reader 1 (p = 0.004) and 87% and 70% for reader 2 (p = 0.004). The specificities of DCE-MRI and T2-weighted MRI with DWI were 68% and 78% for reader 1 (p = 0.002) and 63% and 74% for reader 2 (p < 0.001). The accuracy rates of DCE-MRI and T2-weighted MRI with DWI were 72% and 73% for reader 1 (p > 0.05) and 71% and 73% for reader 2 (p > 0.05). The areas under the receiver operating characteristic curve for DCE-MRI and T2-weighted MRI with DWI were 0.77 and 0.77 for reader 1 and 0.85 and 0.81 for reader 2.
For prediction of local tumor progression of prostate cancer after high-intensity focused ultrasonic ablation, DCE-MRI was more sensitive than T2-weighted MRI with DWI, but T2-weighted MRI with DWI was more specific than DCE-MRI.
本研究旨在评估动态对比增强磁共振成像(DCE-MRI)以及联合扩散加权成像(DWI)的T2加权磁共振成像对局部前列腺癌高强度聚焦超声消融术后局部肿瘤进展的诊断效能。
27例高强度聚焦超声消融术后前列腺特异性抗原水平升高的患者接受了磁共振成像检查及直肠内活检。对六个前列腺区域的磁共振图像和活检结果进行相关性分析。若活检结果显示癌灶,则将治疗后残留或复发性前列腺癌定义为局部肿瘤进展。两名对临床结果和活检结果不知情的阅片者采用5分制独立评估DCE-MR图像以及T2加权和扩散加权磁共振图像。通过使用经Bonferroni校正的McNemar检验、广义估计方程以及受试者操作特征分析对结果进行比较。
高强度聚焦超声消融术后,18例患者的162个区域中有54个(33%)在病理上检测到局部肿瘤进展。阅片者1对DCE-MRI以及联合DWI的T2加权MRI的敏感度分别为80%和63%(p = 0.004),阅片者2的敏感度分别为87%和70%(p = 0.004)。阅片者1对DCE-MRI以及联合DWI的T2加权MRI的特异度分别为68%和78%(p = 0.002),阅片者2的特异度分别为63%和74%(p < 0.001)。阅片者1对DCE-MRI以及联合DWI的T2加权MRI的准确率分别为72%和73%(p > 0.05),阅片者2的准确率分别为71%和73%(p > 0.05)。阅片者1对DCE-MRI以及联合DWI的T2加权MRI的受试者操作特征曲线下面积分别为0.77和0.77,阅片者2的分别为0.85和0.81。
对于预测高强度聚焦超声消融术后前列腺癌的局部肿瘤进展,DCE-MRI比联合DWI的T2加权MRI更敏感,但联合DWI的T2加权MRI比DCE-MRI更具特异性。